(lp0
S"Anthera Pharmaceuticals Inc  Is Getting Cheaper: Is It Still ... Insider Financial - 14 hours ago Anthera Pharmaceuticals Inc  is one we've looked at a couple of times in the past, and one we've taken something of a contrarian position on as a result of this coverage.Taking a Fresh Look at Anthera Pharmaceuticals, Inc.  - StockNewsJournalTop Institutional Investors That Own Anthera Pharmaceuticals, Inc.  - Post Analyst"
p1
aS'Sorting Out the Technicals on Shares of Anthera Pharmaceuticals Inc  Rives Journal - 14 hours ago Keeping an eye on moving averages for Anthera Pharmaceuticals Inc , the 50-day is 0.54, the 200-day is at 1.91, and the 7-day is 0.39.'
p2
aS'Anthera Pharmaceuticals Inc  May Be Headed To The Right Direction ... Journal Transcript - Apr 3, 2017 Anthera Pharmaceuticals Inc  has today made public the findings it obtained from the Extension Period of the Phase 3 SOLUTION, non-inferiority clinical study in cystic fibrosis among patients struggling with exocrine pancreatic insufficiency .Critical Chart Information For Anthera Pharmaceuticals, Inc.  - NY Stock NewsAnthera Pharmaceuticals, Inc.  traded with volume of 1.56 Million shares ... - StandardOracle'
p3
aS"ANTHERA PHARMACEUTICALS, INC.  Files An 8-K Other Events Market Exclusive - Mar 31, 2017 Anthera Pharmaceuticals, Inc.  is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including enzyme replacement therapies and autoimmune diseases.Anthera Pharmaceuticals Inc.  Moves Lower on Volume Spike for March 31 - Equities.comAnalyst's Predictions on QEP Resources, Inc. , Anthera Pharmaceuticals ... - StockNewsJournal"
p4
aS'Steady Activities: Anthera Pharmaceuticals, Inc.  StandardOracle - Apr 13, 2017 Anthera Pharmaceuticals, Inc.  lost -2.08% to reach $0.39 in the previous trading session. Overall, 1.07 Million shares exchanged hands versus its average trading volume of 2.34 Million shares.Anthera Pharmaceuticals Inc  Forecasted to Earn FY2021 Earnings of $0.07 ... - The Cerbat Gem'
p5
aS'The Charts For Anthera Pharmaceuticals, Inc.  Is Attracting Massive ... NY Stock News - Mar 28, 2017 The technicals for Anthera Pharmaceuticals, Inc.  have taken shape, and with them a comprehensive picture has emerged.'
p6
aS'What Should Investors Make Of The Trading Chart Of Anthera Pharmaceuticals ... NY Stock News - Apr 10, 2017 Anthera Pharmaceuticals, Inc.  is now trading with a very clear set of technicals. Taken together they paint a very compelling picture of how investors and traders should be approaching ANTH.'
p7
aS'Anthera Pharmaceuticals Inc.  Plunges 5.73% on April 06 Equities.com - Apr 6, 2017 Anthera Pharmaceuticals Inc.  had a rough trading day for Thursday April 06 as shares tumbled 5.73%, or a loss of $-0.0235 per share, to close at $0.39.Trending Stock Update: Anthera Pharmaceuticals, Inc.  - StandardOracleAnthera Pharmaceuticals, Inc.  Closed the Last Trading Session at $0.41 - The Newburgh Press'
p8
aS'Equity in Focus: Anthera Pharmaceuticals, Inc.  BVN - 13 hours ago Investors may be checking on some financial ratios for Anthera Pharmaceuticals, Inc. . Currently, the company has a Gross Margin  ratio of -1.964382.'
p9
aS'Anthera Pharmaceuticals Inc.  Settles Into New 52-Week Low on April 07 ... Equities.com - Apr 7, 2017 Shares of Anthera Pharmaceuticals Inc.  sank into a new 52-week low yesterday, and could be a company to watch at the open.'
p10
a.